GlaxoSmithKline Pakistan Share Price, PSX Chart & Forecast (PSX: GLAXO) GlaxoSmithKline Pakistan Limited
Rs315.00
Up +0.18 (+0.06%) on the day
As of close · Source: PSX · End-of-day data, not a live feed
GLAXO key statistics
Session of 28 Oct 2026 · Select ? beside a label for a plain-English definition
- OpenOpenThe price of the first trade in the session. Glossary
- Rs 314.85
- HighHighThe highest price traded during the period — today's session unless stated otherwise. Glossary
- Rs 316.10
- LowLowThe lowest price traded during the period — today's session unless stated otherwise. Glossary
- Rs 312.50
- Prev closeCloseThe official last price of the session. The day's change is measured from the previous close, and it is the reference for the next session. Glossary
- Rs 314.82
- VolumeVolumeThe number of shares traded in the session. A move on heavy volume carries more conviction than the same move on a quiet day. Glossary
- 56,270
- TurnoverTurnoverThe rupee value of shares traded (volume × price). Pakistani market reports often use "turnover" loosely for the number of shares traded, so check the unit. Glossary
- Rs 17.7M
- Market capMarket capitalisationShare price multiplied by the number of shares outstanding — what the market says the whole company is worth. Use it, not the share price, to compare the size of two businesses. Glossary
- Rs 100.32B
- P/E ratioP/E ratioShare price divided by earnings per share — how many rupees you pay for one rupee of annual profit. Compare it only with companies in the same sector. Glossary
- 9.6
- EPSEPS (earnings per share)Net profit divided by shares outstanding — the company's earnings attributable to one share. Rising EPS over several years is the cleanest evidence a business is growing. Glossary
- Rs 31.48
- Dividend yieldDividend yieldAnnual dividend per share divided by the share price, as a percentage. A very high yield is often a warning: the price may have fallen sharply, and the dividend may be cut next. Glossary
- —
- BetaBetaHow much a stock tends to move relative to the market. A beta of 1 moves with it, above 1 amplifies it, below 1 dampens it — it measures co-movement, not quality. Glossary
- 1.04
- ROEROE (return on equity)Net profit as a percentage of shareholders' equity — how efficiently management turns the owners' capital into profit. Consistently high ROE without heavy debt is a sign of a durable business. Glossary
- —
- Book value / shareBook valueAssets minus liabilities — the company's accounting net worth, usually quoted per share. Glossary
- —
- P/B ratioP/B (price-to-book)Share price divided by book value per share. Below 1 means the market values the company at less than its stated net assets — a reason to investigate, not an automatic bargain. Glossary
- —
- 52-week range52-week rangeThe lowest and highest price over the past year. It shows where today's price sits, but a stock near its 52-week low is not automatically cheap. Glossary
-
293.08315.00450.61
— means not available. For GLAXO that is dividend yield, as no cash dividend from the past twelve months is on file; ROE, book value and P/B, which need audited accounts we do not hold yet. We leave a figure blank rather than estimate it.
GLAXO at a glance
What the figures on this page say, in plain English
Strengths
Valued below peers. P/E of 9.6 against a Pharmaceuticals median of 16.8.
Cautions
Near its 52-week low. Trades 7.5% above its 52-week low of Rs 293.08.
Model reads bearish. The automated model reads GLAXO as bearish at 48% confidence.
What this means: each line restates a figure for GLAXO shown on this page and is recomputed after every session. It describes the data; it is not a recommendation to buy or sell.
Model outlook
rule-engine-v2BearishAI signalThe model's directional reading of the stock over the next ten sessions, on a five-step scale from strongly bearish to strongly bullish, built from price and indicator history. A description of the data, not investment advice. Glossary
48% confidenceConfidenceHow strongly the model leans toward its call. It is not the probability of being right — the graded record against the base rate is the figure for that. Glossary · Short Term
The model reads GLAXO as bearish — an overall score of 47/100 from the rule-based fallback, which is a blend of inputs, not a probability. See the graded record and what drove it ↓
Automated model output, not a recommendation. A reading is a statistical lean; weigh it against the live record in the model card.
GLAXO price chart
Daily GLAXO prices with 20- and 50-day averages and Bollinger Bands. Drag to zoom; hover for each day's figures.
27 Oct 2025 – 28 Oct 2026: ▼ −21.19% · high Rs 450.61 · low Rs 293.08
GLAXO share price and analysis
GlaxoSmithKline Pakistan Limited (GLAXO) last traded at Rs 315.00 on the Pakistan Stock Exchange, where it rose 0.06% on the session of 28 October 2026. Volume was 56,270 shares, a turnover of Rs 17.7 million. Over the past year the share has traded between Rs 293.08 and Rs 450.61, putting the current price in the lower part of that range.
The price is between its 20-day (312.56) and 50-day (318.70) moving averages, so the short-term trend is unresolved. The 14-day RSI is 50.7, a neutral reading. ADX at 24.8 indicates a weak or rangebound trend.
With a market capitalisation of about Rs 100.3 billion, this is one of the larger listings on the exchange and is classified under Pharmaceuticals. It trades on a price-to-earnings ratio of 9.6, meaning the market is paying about Rs 9.6 for every rupee of annual earnings. Earnings per share stand at Rs 31.48. A beta of 1.04 against the KSE-100 means the share has moved roughly in line with the wider market over the past year.
GLAXO is the largest Pharmaceuticals company on the exchange by market value, of the 34 we track. Its price-to-earnings ratio of 9.6 compares with the Pharmaceuticals median of 16.8, so it is priced at a clear discount to its sector. Sector medians are taken across the companies we hold fundamentals for and move as those are restated.
Our forecasting model currently reads GLAXO as bearish over a short term horizon, at 48% confidence. The model is computed from the price and indicator history shown on this page. It does not read news, financial statements or management changes, and it is not a recommendation to buy or sell.
This summary is generated from the end-of-day prices and indicators shown on this page and is refreshed after each trading session. It describes the data; it is not a recommendation. See how we collect and check this data and our disclaimer.
Other Pharmaceuticals stocks
GLAXO is a Pharmaceuticals listing. Compare it against the rest of the sector, or read what actually drives Pharmaceuticals companies on the PSX.
-
ABOTAbbott Laboratories (Pakistan) Limited960.74▼ −0.66% -
DIILDiamond Industries Limited77.34▼ −8.58% -
GOCGOC (Pak) Limited.234.72▲ +5.53% -
OTSUOtsuka Pakistan Limited398.20▲ +10.00% -
OMLOlympia Mills Limited87.35▲ +10.00%
Learn how to read this page
- How to Read a Stock Page Without Fooling Yourself
A walk through every number on a PSX stock page — price, volume, P/E, RSI, our own AI signal — and an honest account of how much weight each one deserves.
- Technical Analysis on the PSX: Using Moving Averages, RSI and MACD Without Fooling Yourself
Moving averages, RSI and MACD describe past prices — nothing more. Used in the right order they keep you honest; used as signals they lose money. Here are the mechanics that actually work on the PSX, and where thin volume and circuit breakers make indicators meaningless.
- How to Read a PSX Company's Financial Statements
Annual reports are free, audited and almost never read. A walk through a PSX income statement and balance sheet, with EPS, P/E, ROE and dividend yield worked by hand — and the red flags those ratios quietly hide.
GLAXO technical indicators — RSI, MACD & moving averages
Momentum and trend gauges for GLAXO after the session of 28 Oct 2026, each with a one-line reading of what the number means.
RSI (14)
RSI (Relative Strength Index)A momentum gauge from 0 to 100, usually over 14 days. Above 70 is called overbought and below 30 oversold, but in a strong trend RSI can stay there for weeks — it is not a buy or sell instruction. GlossaryGLAXO reads 50.7 — neutral (between 30 and 70). Above 70 is conventionally read as overbought, below 30 as oversold; dashed lines mark both.
MACD (12, 26, 9)
MACDThe 12-day exponential moving average minus the 26-day, with a 9-day signal line on top. A cross above the signal line means short-term momentum has turned up; it lags, and misfires in sideways markets. GlossaryGLAXO reads -1.803 — above its signal line: momentum improving. Bars show the gap between MACD and its signal line.
- RSI (14)
- 50.7
- Neutral (between 30 and 70)
- Stochastic %K
- 82.8
- Overbought zone (above 80)
- ADX (14)ADX (Average Directional Index)Measures trend strength from 0 to 100 without saying which direction. Below about 20 the market is ranging; above 25 a real trend is present. Glossary
- 24.8
- Weak or sideways trend (below 25)
- Williams %R
- -17.2
- Overbought zone (above −20)
- SMA 20SMA 20The average closing price of the last 20 sessions, redrawn each day — a short-term trend line. Moving averages describe what has happened; they do not predict. Glossary
- 312.56
- Price is 0.8% above it
- SMA 50SMA 50The average closing price of the last 50 sessions — the most watched medium-term trend line. Price above a rising 50-day average is a common definition of an uptrend. Glossary
- 318.70
- Price is 1.2% below it
- MACD
- -1.803
- Above its signal line: momentum improving
- ATR (14)
- 2.642
- A typical day moves about 0.8% of the price
- Bollinger upperBollinger BandsA moving average with bands two standard deviations above and below; they widen as volatility rises. Touching the upper band means the price is stretched, not that it must reverse. Glossary
- 317.35
- Price is 0.7% below it
- Bollinger lower
- 307.76
- Price is 2.4% above it
- Momentum (10)
- 2.56
- Higher than 10 sessions ago
- Technical score
- 44
- Middling, on a 0–100 scale
GLAXO fundamentals & valuation ratios
Set beside the median Pharmaceuticals company
| Measure | GLAXO | Sector median |
|---|---|---|
| Market cap | Rs 100.32B | No. 1 of 34 by size |
| P/E ratio | 9.6 | 16.8 |
| EPS | Rs 31.48 | — |
| P/B ratio | — | — |
| Dividend yield | — | — |
| ROE | — | — |
| Beta | 1.04 | — |
| Volatility (annualised) | 34.0% | — |
Fundamental score
56/100
What this means: GLAXO scores 56 on a 0–100 check built only from the figures we hold for it — P/E and volatility. 50 is neutral; compare it within a sector, not across sectors. A dash in the table is a figure we do not hold for GLAXO; it adds nothing to the score rather than being guessed.
GLAXO price history — last 30 sessions
Daily open, high, low and close, newest first
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Wed, 28 Oct 2026 | 314.85 | 316.10 | 312.50 | 315.00 | ▲ +0.06% | 56,270 |
| Tue, 27 Oct 2026 | 307.31 | 314.82 | 307.31 | 314.82 | ▲ +2.44% | 101,136 |
| Mon, 26 Oct 2026 | 309.23 | 309.23 | 307.31 | 307.31 | ▼ −0.62% | 51,447 |
| Fri, 23 Oct 2026 | 310.22 | 310.22 | 309.23 | 309.23 | ▼ −0.32% | 81,086 |
| Thu, 22 Oct 2026 | 313.52 | 313.52 | 310.22 | 310.22 | ▼ −1.05% | 31,679 |
| Wed, 21 Oct 2026 | 315.05 | 315.05 | 313.52 | 313.52 | ▼ −0.49% | 22,770 |
| Tue, 20 Oct 2026 | 313.98 | 315.05 | 313.98 | 315.05 | ▲ +0.34% | 110,036 |
| Mon, 19 Oct 2026 | 312.45 | 313.98 | 312.45 | 313.98 | ▲ +0.49% | 113,894 |
| Fri, 16 Oct 2026 | 311.85 | 312.45 | 311.85 | 312.45 | ▲ +0.19% | 13,698 |
| Thu, 15 Oct 2026 | 312.44 | 312.44 | 311.85 | 311.85 | ▼ −0.19% | 82,470 |
| Wed, 14 Oct 2026 | 311.19 | 312.44 | 311.19 | 312.44 | ▲ +0.40% | 57,509 |
| Tue, 13 Oct 2026 | 312.00 | 312.00 | 311.19 | 311.19 | ▼ −0.26% | 62,009 |
| Mon, 12 Oct 2026 | 316.60 | 316.60 | 312.00 | 312.00 | ▼ −1.45% | 63,979 |
| Fri, 9 Oct 2026 | 312.85 | 316.60 | 312.85 | 316.60 | ▲ +1.20% | 138,904 |
| Thu, 8 Oct 2026 | 314.58 | 314.58 | 312.85 | 312.85 | ▼ −0.55% | 54,661 |
| Wed, 7 Oct 2026 | 314.49 | 314.58 | 314.49 | 314.58 | ▲ +0.03% | 56,438 |
| Tue, 6 Oct 2026 | 307.82 | 314.49 | 307.82 | 314.49 | ▲ +2.17% | 118,662 |
| Mon, 5 Oct 2026 | 312.18 | 312.18 | 307.82 | 307.82 | ▼ −1.40% | 62,717 |
| Fri, 2 Oct 2026 | 313.55 | 313.55 | 312.18 | 312.18 | ▼ −0.44% | 40,346 |
| Thu, 1 Oct 2026 | 312.94 | 313.55 | 312.94 | 313.55 | ▲ +0.19% | 132,608 |
| Wed, 30 Sep 2026 | 314.58 | 314.58 | 312.94 | 312.94 | ▼ −0.52% | 103,555 |
| Tue, 29 Sep 2026 | 316.42 | 316.42 | 314.58 | 314.58 | ▼ −0.58% | 39,731 |
| Mon, 28 Sep 2026 | 314.37 | 316.42 | 314.37 | 316.42 | ▲ +0.65% | 65,260 |
| Fri, 25 Sep 2026 | 315.58 | 315.58 | 314.37 | 314.37 | ▼ −0.38% | 87,742 |
| Thu, 24 Sep 2026 | 321.36 | 321.36 | 315.58 | 315.58 | ▼ −1.80% | 118,541 |
| Wed, 23 Sep 2026 | 322.57 | 322.57 | 321.36 | 321.36 | ▼ −0.38% | 122,302 |
| Tue, 22 Sep 2026 | 322.61 | 322.61 | 322.57 | 322.57 | ▼ −0.01% | 71,084 |
| Mon, 21 Sep 2026 | 320.99 | 322.61 | 320.99 | 322.61 | ▲ +0.50% | 100,137 |
| Fri, 18 Sep 2026 | 314.61 | 320.99 | 314.61 | 320.99 | ▲ +2.03% | 239,927 |
| Thu, 17 Sep 2026 | 311.33 | 314.61 | 311.33 | 314.61 | ▲ +1.05% | 174,861 |
All figures in PKR, end of day, sourced from the Pakistan Stock Exchange.
GLAXO — frequently asked questions
What is GLAXO's share price today?
GlaxoSmithKline Pakistan Limited (GLAXO) last traded at Rs 315.00 on the Pakistan Stock Exchange, up 0.06% on the session of 28 October 2026. The day's range was Rs 312.50 to Rs 316.10 on 56,270 shares. These are end-of-day figures published by the exchange, not a live trading feed.
What is the 52-week high and low for GLAXO on the PSX?
GLAXO has traded between Rs 293.08 and Rs 450.61 over the past twelve months on the Pakistan Stock Exchange. The range is computed from the end-of-day closes we hold for the stock and is refreshed after every session.
Is GLAXO Shariah-compliant on the PSX?
Yes. The Pakistan Stock Exchange lists GLAXO in its Shariah-screened KMI All Share index, which means the company passed the screening set with Meezan Bank at the last review — the business-activity test plus the financial ratio tests on interest-bearing debt, illiquid assets and non-compliant income. Screening is periodic, so a company can be dropped when a ratio breaks; check the current KMI index membership before relying on it.
Which PSX indices is GLAXO part of?
GLAXO is a constituent of the KSE All Share, KMI All Share and KSE-100. KSE-100 membership means it is one of the hundred companies the headline PSX benchmark is built from. Index membership is taken from the exchange's own published listing for each session.
Is GLAXO expensive? What are its valuation ratios?
GLAXO trades on a price-to-earnings ratio of 9.6, so the market is paying about Rs 9.6 for each rupee of annual earnings and earnings per share of Rs 31.48. Ratios are only meaningful next to the rest of the sector — a low multiple that the whole sector shares is usually a sector problem rather than a bargain, which is why the sector page is linked from this one.
What is the model outlook for GLAXO?
Our model currently reads GLAXO as bearish over a short term horizon, at 48% confidence. It is computed from this stock's own price and indicator history. It does not read news, financial statements or management changes, its graded record against the base rate is published on the page, and it is not investment advice.
Answers are generated from the end-of-day figures on this page and refreshed after each session. See all frequently asked questions or our methodology.
About this data
Prices, volumes and indicators for GLAXO are end-of-day figures collected from the Pakistan Stock Exchange and recomputed after each session — they are not a live trading feed and may lag the market. Forecasts are the output of logistic-v1, an automated logistic-regression model trained on price history alone; it does not read news, filings or management changes, no analyst reviews its output before publication, and its track record is published in full on our model accuracy page.
PSX Expert is an independent analytics publisher. We are not licensed by the SECP as a securities adviser, investment adviser, research analyst or broker-dealer, and nothing on this page is a personal recommendation. Past performance and back-tested results do not predict future results. Read our methodology, who we are and the full disclaimer before acting on anything here.